Animal Health
Advancing therapies for animal health requires study models that reflect disease biology and generate meaningful translational insights. Transpharmation offers a comprehensive portfolio of naturally occurring and induced disease models in both dogs and cats, supporting translational research, target validation, efficacy assessment, biomarker development, pharmacokinetic studies, and regulatory programs. Through client-tailored study designs, translationally relevant endpoints, and integrated scientific, veterinary, and operational expertise, we help generate the data needed for confident development decisions.
For over a decade, Transpharmation has been providing research and development services in the companion animal market. Our scientists and veterinarians are leading experts in the field of cognition and general behavior, anxiety, aging, and life-span development.
Our colony encompasses a wide variety of companion animal populations, including both general research cohorts and disease-specific groups with naturally occurring conditions such as osteoarthritis, mitral valve disease, periodontal disease, atopic dermatitis and other age-associated disorders. In addition, we offer induced disease models, including type I diabetes, obesity, and gut dysbiosis, providing versatile and clinically relevant platforms to support therapeutic development across multiple indications.
Leading veterinary medicine developers trust us to help guide and conduct innovative research studies and early proof-of-concept evaluations that provide evidence to support product claims and regulatory submissions.
Our goal is to help evaluate and develop innovative products which improve the quality of life of companion dogs and cats.
Relevant services
Platforms used in this area
Electroencephalography (EEG) In-vivo rodent telemetry
Imaging Services Companion animal imaging
Operant Platform Motivation, impulsivity, attention, cognition, memory
PK/PD Studies Endpoints for lead optimization
PK-Bridge PK studies for discovery budgets
Cognitive Assessment Aged-dog memory and cognitive decline
Have a program in mind?
Whether you are evaluating a new therapeutic candidate, assessing efficacy, advancing biomarker strategies, or supporting a regulatory program, our animal health team can develop a customized study design using disease models in dogs and cats and incorporating the endpoints most relevant to your research objectives. Partner with Transpharmation to access the expertise and capabilities needed to generate the data your program needs.